SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,526,686 | +191.9% | 74,183 | +566.8% | 0.00% | +200.0% |
| Q2 2023 | $523,098 | -7.6% | 11,125 | -17.5% | 0.00% | 0.0% |
| Q1 2023 | $566,124 | -3.7% | 13,492 | -12.4% | 0.00% | 0.0% |
| Q4 2022 | $587,661 | -22.6% | 15,408 | -20.5% | 0.00% | -50.0% |
| Q3 2022 | $759,000 | -58.6% | 19,370 | -66.4% | 0.00% | -50.0% |
| Q2 2022 | $1,832,000 | -83.3% | 57,723 | -82.6% | 0.00% | -81.0% |
| Q1 2022 | $10,981,000 | -44.8% | 331,746 | -29.0% | 0.02% | -41.7% |
| Q4 2021 | $19,882,000 | -15.5% | 467,367 | -12.4% | 0.04% | -18.2% |
| Q3 2021 | $23,520,000 | +149.2% | 533,700 | +221.2% | 0.04% | +175.0% |
| Q2 2021 | $9,440,000 | +1085.9% | 166,171 | +1461.6% | 0.02% | +1500.0% |
| Q1 2021 | $796,000 | +159.3% | 10,641 | +199.7% | 0.00% | 0.0% |
| Q4 2020 | $307,000 | -20.7% | 3,550 | +28.7% | 0.00% | – |
| Q3 2019 | $387,000 | -22.1% | 2,758 | +0.3% | 0.00% | -100.0% |
| Q2 2019 | $497,000 | +2.9% | 2,749 | -9.5% | 0.00% | 0.0% |
| Q1 2019 | $483,000 | -50.6% | 3,037 | -70.3% | 0.00% | 0.0% |
| Q4 2018 | $978,000 | -36.0% | 10,209 | -5.6% | 0.00% | 0.0% |
| Q3 2018 | $1,527,000 | -75.1% | 10,814 | -72.4% | 0.00% | -83.3% |
| Q2 2018 | $6,131,000 | -57.6% | 39,171 | -56.3% | 0.01% | -62.5% |
| Q1 2018 | $14,453,000 | +82.8% | 89,731 | +86.9% | 0.02% | +100.0% |
| Q4 2017 | $7,908,000 | +530.1% | 48,010 | +138.3% | 0.01% | +700.0% |
| Q3 2017 | $1,255,000 | +28.3% | 20,148 | +64.0% | 0.00% | 0.0% |
| Q2 2017 | $978,000 | -16.4% | 12,286 | -25.4% | 0.00% | -50.0% |
| Q1 2017 | $1,170,000 | +479.2% | 16,460 | +161.0% | 0.00% | – |
| Q1 2016 | $202,000 | -70.6% | 6,306 | -46.5% | 0.00% | -100.0% |
| Q4 2015 | $688,000 | -5.2% | 11,794 | -31.3% | 0.00% | 0.0% |
| Q3 2015 | $726,000 | – | 17,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |